Psoriatic arthritis: state of the art review (Q38985830)

From Wikidata

Jump to navigation Jump to search

scientific article published in February 2017

edit

Language	Label	Description	Also known as
English	Psoriatic arthritis: state of the art review	scientific article published in February 2017

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PMC publication ID

6297592

retrieved

1 July 2019

reference URL

http://europepmc.org/abstract/PMC/6297592

title

Psoriatic arthritis: state of the art review (English)

1 reference

stated in

Europe PubMed Central

PMC publication ID

6297592

retrieved

1 July 2019

reference URL

http://europepmc.org/abstract/PMC/6297592

main subject

psoriatic arthritis

1 reference

based on heuristic

inferred from title

author

Philip Helliwell

series ordinal

2

object named as

Philip S Helliwell

0 references

Laura C. Coates

series ordinal

1

object named as

Laura C Coates

0 references

publication date

1 February 2017

1 reference

stated in

Europe PubMed Central

PMC publication ID

6297592

retrieved

1 July 2019

reference URL

http://europepmc.org/abstract/PMC/6297592

published in

Clinical Medicine

1 reference

stated in

Europe PubMed Central

PMC publication ID

6297592

retrieved

1 July 2019

reference URL

http://europepmc.org/abstract/PMC/6297592

volume

17

1 reference

stated in

Europe PubMed Central

PMC publication ID

6297592

retrieved

1 July 2019

reference URL

http://europepmc.org/abstract/PMC/6297592

issue

1

1 reference

stated in

Europe PubMed Central

PMC publication ID

6297592

retrieved

1 July 2019

reference URL

http://europepmc.org/abstract/PMC/6297592

page(s)

65-70

1 reference

stated in

Europe PubMed Central

PMC publication ID

6297592

retrieved

1 July 2019

reference URL

http://europepmc.org/abstract/PMC/6297592

cites work

Interventions for psoriatic arthritis.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/28148584

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of disability and quality of life in rheumatoid and psoriatic arthritis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/28148584

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy and safety of leflunomide in the treatment of psoriatic arthritis and psoriasis: a multinational, double-blind, randomized, placebo-controlled clinical trial

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/28148584

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Etanercept treatment of psoriatic arthritis: safety, efficacy, and effect on disease progression

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/28148584

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Infliximab improves signs and symptoms of psoriatic arthritis: results of the IMPACT 2 trial

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/28148584

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sustained benefits of infliximab therapy for dermatologic and articular manifestations of psoriatic arthritis: results from the infliximab multinational psoriatic arthritis controlled trial (IMPACT)

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/28148584

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adalimumab for the treatment of patients with moderately to severely active psoriatic arthritis: results of a double-blind, randomized, placebo-controlled trial

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/28148584

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Classification criteria for psoriatic arthritis: development of new criteria from a large international study

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/28148584

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Predictors for radiological damage in psoriatic arthritis: results from a single centre

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/28148584

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Risk of Myocardial Infarction in Patients With Psoriasis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/28148584

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Incidence and clinical predictors of psoriatic arthritis in patients with psoriasis: a population-based study

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/28148584

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Golimumab, a new human tumor necrosis factor alpha antibody, administered every four weeks as a subcutaneous injection in psoriatic arthritis: Twenty-four-week efficacy and safety results of a randomized, placebo-controlled study

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/28148584

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The prevalence of psoriatic arthritis in people with psoriasis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/28148584

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Predictors of response to intra-articular steroid injection in psoriatic arthritis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/28148584

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A randomized placebo-controlled trial of methotrexate in psoriatic arthritis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/28148584

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Smoking and delay to diagnosis are associated with poorer functional outcome in psoriatic arthritis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/28148584

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical response, drug survival, and predictors thereof among 548 patients with psoriatic arthritis who switched tumor necrosis factor α inhibitor therapy: results from the Danish Nationwide DANBIO Registry

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/28148584

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The TICOPA protocol (TIght COntrol of Psoriatic Arthritis): a randomised controlled trial to compare intensive management versus standard care in early psoriatic arthritis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/28148584

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reduced joint counts misclassify patients with oligoarticular psoriatic arthritis and miss significant numbers of patients with active disease

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/28148584

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy and safety of ustekinumab in patients with active psoriatic arthritis: 1 year results of the phase 3, multicentre, double-blind, placebo-controlled PSUMMIT 1 trial.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/28148584

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of certolizumab pegol on signs and symptoms in patients with psoriatic arthritis: 24-week results of a Phase 3 double-blind randomised placebo-controlled study (RAPID-PsA).

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/28148584

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Diagnostic delay of more than 6 months contributes to poor radiographic and functional outcome in psoriatic arthritis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/28148584

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of psoriatic arthritis in a phase 3 randomised, placebo-controlled trial with apremilast, an oral phosphodiesterase 4 inhibitor

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/28148584

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Development of criteria to distinguish inflammatory from noninflammatory arthritis, enthesitis, dactylitis, and spondylitis: a report from the GRAPPA 2013 Annual Meeting.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/28148584

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High prevalence of metabolic syndrome and of insulin resistance in psoriatic arthritis is associated with the severity of underlying disease.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/28148584

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Secukinumab in plaque psoriasis--results of two phase 3 trials

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/28148584

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Secukinumab is superior to ustekinumab in clearing skin of subjects with moderate to severe plaque psoriasis: CLEAR, a randomized controlled trial

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/28148584

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Secukinumab, a human anti-interleukin-17A monoclonal antibody, in patients with psoriatic arthritis (FUTURE 2): a randomised, double-blind, placebo-controlled, phase 3 trial

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/28148584

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Secukinumab Inhibition of Interleukin-17A in Patients with Psoriatic Arthritis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/28148584

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of tight control of inflammation in early psoriatic arthritis (TICOPA): a UK multicentre, open-label, randomised controlled trial

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/28148584

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Limitations of clinical trials in chronic diseases: is the efficacy of methotrexate (MTX) underestimated in polyarticular psoriatic arthritis on the basis of limitations of clinical trials more than on limitations of MTX, as was seen in rheumatoid a

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/28148584

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

European League Against Rheumatism (EULAR) recommendations for the management of psoriatic arthritis with pharmacological therapies: 2015 update

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/28148584

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Methotrexate Efficacy in the Tight Control in Psoriatic Arthritis Study

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/28148584

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Group for Research and Assessment of Psoriasis and Psoriatic Arthritis 2015 Treatment Recommendations for Psoriatic Arthritis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/28148584

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of screening questionnaires to identify psoriatic arthritis in a primary-care population: a cross-sectional study

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/28148584

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Psoriatic arthritis (PSA)--an analysis of 220 patients

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/28148584

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Psoriatic arthritis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/28148584

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

DOI

10.7861/CLINMEDICINE.17-1-65

1 reference

stated in

Europe PubMed Central

PMC publication ID

6297592

retrieved

1 July 2019

reference URL

http://europepmc.org/abstract/PMC/6297592

PMC publication ID

6297592

1 reference

stated in

Europe PubMed Central

PMC publication ID

6297592

retrieved

1 July 2019

reference URL

http://europepmc.org/abstract/PMC/6297592

PubMed publication ID

28148584

1 reference

stated in

Europe PubMed Central

PMC publication ID

6297592

retrieved

1 July 2019

reference URL

http://europepmc.org/abstract/PMC/6297592

Scopus EID

2-s2.0-85016023755

0 references

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38985830&oldid=1800812437"